Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics

被引:55
作者
Gucciardo, Erika [1 ]
Sugiyama, Nami [1 ,2 ]
Lehti, Kaisa [1 ]
机构
[1] Univ Helsinki, Biomedicum Helsinki, Res Programs Unit, FIN-00014 Helsinki, Finland
[2] Swiss Fed Inst Technol, Dept Biosyst Sci & Bioengn, CH-4058 Basel, Switzerland
关键词
Eph receptors; Cancer; Stem cells; Cell plasticity; Invasion; RECEPTOR TYROSINE KINASE; GROWTH-FACTOR RECEPTORS; PROSTATE-CANCER; VASCULOGENIC MIMICRY; MOLECULAR MARKERS; COLORECTAL-CANCER; LIGAND-BINDING; MELANOMA-CELLS; C-SRC; 1-MATRIX METALLOPROTEINASE;
D O I
10.1007/s00018-014-1633-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The erythropoietin-producing hepatocellular (Eph) receptors comprise the largest family of receptor tyrosine kinases (RTKs). Initially regarded as axon-guidance and tissue-patterning molecules, Eph receptors have now been attributed with various functions during development, tissue homeostasis, and disease pathogenesis. Their ligands, ephrins, are synthesized as membrane-associated molecules. At least two properties make this signaling system unique: (1) the signal can be simultaneously transduced in the receptor- and the ligand-expressing cell, (2) the signaling outcome through the same molecules can be opposite depending on cellular context. Moreover, shedding of Eph and ephrin ectodomains as well as ligand-dependent and -independent receptor crosstalk with other RTKs, proteases, and adhesion molecules broadens the repertoire of Eph/ephrin functions. These integrated pathways provide plasticity to cell-microenvironment communication in varying tissue contexts. The complex molecular networks and dynamic cellular outcomes connected to the Eph/ephrin signaling in tumor-host communication and stem cell niche are the main focus of this review.
引用
收藏
页码:3685 / 3710
页数:26
相关论文
共 285 条
[1]   Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis [J].
Adams, RH ;
Wilkinson, GA ;
Weiss, C ;
Diella, F ;
Gale, NW ;
Deutsch, U ;
Risau, W ;
Klein, R .
GENES & DEVELOPMENT, 1999, 13 (03) :295-306
[2]   Soluble ephrin a1 is necessary for the growth of HeLa and SK-BR3 cells [J].
Alford, Spencer ;
Watson-Hurthig, Adam ;
Scott, Nadia ;
Carette, Amanda ;
Lorimer, Heather ;
Bazowski, Jessa ;
Howard, Perry L. .
CANCER CELL INTERNATIONAL, 2010, 10
[3]   Tissue transglutaminase clusters soluble A-type ephrins into functionally active high molecular weight oligomers [J].
Alford, Spencer C. ;
Bazowski, Jessa ;
Lorimer, Heather ;
Elowe, Sabine ;
Howard, Perry L. .
EXPERIMENTAL CELL RESEARCH, 2007, 313 (20) :4170-4179
[4]   Identification of c-Src tyrosine kinase substrates in platelet-derived growth factor receptor signaling [J].
Amanchy, Ramars ;
Zhong, Jun ;
Hong, Rosa ;
Kim, James H. ;
Gucek, Marjan ;
Cole, Robert N. ;
Molina, Henrik ;
Pandey, Akhilesh .
MOLECULAR ONCOLOGY, 2009, 3 (5-6) :439-450
[5]   EphA receptors direct the differentiation of mammalian neural precursor cells through a mitogen-activated protein kinase-dependent pathway [J].
Aoki, M ;
Yamashita, T ;
Tohyama, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (31) :32643-32650
[6]   Eph/ephrin signaling: networks [J].
Arvanitis, Dina ;
Davy, Alice .
GENES & DEVELOPMENT, 2008, 22 (04) :416-429
[7]   Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells [J].
Astin, Jonathan W. ;
Batson, Jennifer ;
Kadir, Shereen ;
Charlet, Jessica ;
Persad, Raj A. ;
Gillatt, David ;
Oxley, Jon D. ;
Nobes, Catherine D. .
NATURE CELL BIOLOGY, 2010, 12 (12) :1194-U175
[8]   Membrane type 1-matrix metalloproteinase: Substrate diversity in pericellular proteolysis [J].
Barbolina, Maria V. ;
Stack, M. Sharon .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2008, 19 (01) :24-33
[9]   B61 IS A LIGAND FOR THE ECK RECEPTOR PROTEIN-TYROSINE KINASE [J].
BARTLEY, TD ;
HUNT, RW ;
WELCHER, AA ;
BOYLE, WJ ;
PARKER, VP ;
LINDBERG, RA ;
LU, HS ;
COLOMBERO, AM ;
ELLIOTT, RL ;
GUTHRIE, BA ;
HOLST, PL ;
SKRINE, JD ;
TOSO, RJ ;
ZHANG, M ;
FERNANDEZ, E ;
TRAIL, G ;
VARNUM, B ;
YARDEN, Y ;
HUNTER, T ;
FOX, GM .
NATURE, 1994, 368 (6471) :558-560
[10]   EphB receptor activity suppresses colorectal cancer progression [J].
Batlle, E ;
Bacani, J ;
Begthel, H ;
Jonkeer, S ;
Gregorieff, A ;
van de Born, M ;
Malats, N ;
Sancho, E ;
Boon, E ;
Pawson, T ;
Gallinger, S ;
Pals, S ;
Clevers, H .
NATURE, 2005, 435 (7045) :1126-1130